Status:
COMPLETED
Effects of Telehealth Initiative on Lupus Patients
Lead Sponsor:
Selcuk University
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
SLE is mostly seen in young women and causes significant deformity in patients. In SLE, disease activity, body damage due to disease or treatment, comorbidities, and drugs affect body image negatively...
Detailed Description
Telehealth has been proposed as a component of patient education for disease management. Telehealth, which is defined as the remote delivery of health services via telecommunication tools including te...
Eligibility Criteria
Inclusion
- Those between the ages of 18-45,
- Diagnosed with SLE disease
- Those who are in remission of the disease
- Those who do not use biological DMARDs
- Non-smokers
- Those who do not drink alcohol
- Those with low disease activity score,
- Neurological, psychiatric disease and non-malignant,
- Individuals who are literate, able to communicate verbally and agree to participate in the study, among those evaluated and approved by their physicians.
Exclusion
- Having a chronic disease other than SLE
- Having a rheumatological disease other than SLE
- Having a disability to use the phone
- Those with hearing loss or visual impairment,
- Those who have undergone changes in the treatment process and those who practice non-drug therapy during the study will not be included in the study.
- In determining the inclusion, exclusion and termination criteria, both the literature and the consultation of a specialist in the field were taken.
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05329831
Start Date
March 15 2022
End Date
June 30 2022
Last Update
October 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Selcuk University Hospital
Konya, Turkey (Türkiye), 42550